Dimensional Fund Advisors LP Has $119.93 Million Stock Holdings in Teleflex Incorporated $TFX

Key Points

• Dimensional Fund Advisors LP increased its stake in Teleflex Incorporated by 69.5% during Q1, owning approximately 1.96% of the company, worth around $119.9 million.
• Teleflex reported $3.73 earnings per share for the last quarter, surpassing analysts' expectations, and the company had a revenue growth of 4.2% year-over-year.
• The company announced a quarterly dividend of $0.34 per share, representing an annual yield of 1.1%, with a payout ratio of 32.00%.

Dimensional Fund Advisors LP raised its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 69.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 867,864 shares of the medical technology company's stock after purchasing an additional 355,720 shares during the quarter. Dimensional Fund Advisors LP owned 1.96% of Teleflex worth $119,927,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of TFX. Mariner LLC boosted its holdings in shares of Teleflex by 7.9% during the 4th quarter. Mariner LLC now owns 5,430 shares of the medical technology company's stock valued at $966,000 after acquiring an additional 396 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its holdings in shares of Teleflex by 0.4% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock valued at $3,614,000 after acquiring an additional 74 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Teleflex by 198.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 4,449 shares of the medical technology company's stock valued at $792,000 after acquiring an additional 2,958 shares in the last quarter. Dark Forest Capital Management LP boosted its holdings in shares of Teleflex by 177.5% during the 4th quarter. Dark Forest Capital Management LP now owns 2,320 shares of the medical technology company's stock valued at $413,000 after acquiring an additional 1,484 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. acquired a new stake in shares of Teleflex during the 4th quarter valued at $606,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Insider Transactions at Teleflex

In other Teleflex news, Director Stuart A. Randle acquired 1,000 shares of the stock in a transaction dated Tuesday, August 5th. The stock was purchased at an average cost of $115.86 per share, with a total value of $115,860.00. Following the transaction, the director owned 7,547 shares in the company, valued at approximately $874,395.42. The trade was a 15.27% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Andrew A. Krakauer acquired 1,000 shares of the stock in a transaction dated Tuesday, August 5th. The stock was acquired at an average cost of $115.25 per share, with a total value of $115,250.00. Following the completion of the transaction, the director owned 7,192 shares in the company, valued at approximately $828,878. This represents a 16.15% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 5,500 shares of company stock worth $633,590. Corporate insiders own 1.40% of the company's stock.

Teleflex Trading Down 2.5%

Shares of TFX stock traded down $3.22 during mid-day trading on Thursday, hitting $126.28. The company's stock had a trading volume of 436,361 shares, compared to its average volume of 586,802. The company's fifty day simple moving average is $118.88 and its 200-day simple moving average is $129.69. Teleflex Incorporated has a 52 week low of $108.90 and a 52 week high of $249.90. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The company has a market cap of $5.58 billion, a PE ratio of 29.71, a P/E/G ratio of 1.81 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping the consensus estimate of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The firm had revenue of $780.90 million during the quarter, compared to analyst estimates of $771.53 million. During the same period last year, the company posted $3.42 EPS. The business's quarterly revenue was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be given a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. Teleflex's dividend payout ratio (DPR) is 32.00%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on TFX. Truist Financial cut their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a report on Monday, May 5th. Wells Fargo & Company cut their price objective on Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Morgan Stanley cut their target price on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a report on Monday, May 5th. Royal Bank Of Canada lifted their target price on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a report on Friday, August 1st. Finally, Wall Street Zen raised Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $141.57.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.